Psychiatric sequelae of Parkinson disease: a case report.
Foley
Sharon R
SR
Department of Psychiatry and Mental Health Research, St Vincent's University Hospital, University College Dublin, Elm Park, Dublin 4, Ireland. sharonfoley1@hotmail.com
Arthur
Ken
K
Kelly
Brendan D
BD
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects; D000077465:Cabergoline; D002230:Carbidopa / Q000008:administration & dosage; D003192:Compulsive Behavior / Q000139:chemically induced*; D004338:Drug Combinations; D004873:Ergolines / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000523:psychology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage; D012720:Severity of Illness Index; D012742:Sex Offenses / Q000523:psychology
D000978:Antiparkinson Agents; D000077465:Cabergoline; D002230:Carbidopa; D004338:Drug Combinations; D004873:Ergolines; D007980:Levodopa; D017367:Selective Serotonin Reuptake Inhibitors; C009265:carbidopa, levodopa drug combination